Kymera Therapeutics, Inc. - Common Stock (KYMR)

Historical Holders from Q3 2020 to Q1 2025

Symbol
KYMR on Nasdaq
CUSIP
501575104
Type / Class
Equity / Common Stock
Shares outstanding
64.7M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
71.7M
Holdings value
$2.89B
% of all portfolios
0.004%
Grand Portfolio weight change
+0%
Number of holders
176
Number of buys
81
Number of sells
-86
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Kymera Therapeutics, Inc. - Common Stock (KYMR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WELLINGTON MANAGEMENT GROUP LLP 8.2% $145M 5.31M Wellington Management Group LLP Dec 31, 2024

Institutional Holders of Kymera Therapeutics, Inc. - Common Stock (KYMR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 588K $16.1M -$430K $27.37 14
2024 Q4 71.7M $2.89B +$18.8M $40.23 176
2024 Q3 69M $3.26B -$2.27M $47.33 173
2024 Q2 67.4M $2.01B +$10.1M $29.85 153
2024 Q1 67.1M $2.7B +$296M $40.20 159
2023 Q4 60.4M $1.54B +$89.3M $25.46 132
2023 Q3 57.2M $795M -$17.6M $13.90 118
2023 Q2 58M $1.33B +$24.1M $22.99 121
2023 Q1 56.8M $1.68B +$23.2M $29.63 121
2022 Q4 56.1M $1.4B +$97.8M $24.96 114
2022 Q3 51M $1.11B +$28M $21.77 114
2022 Q2 49.2M $969M +$11.5M $19.69 97
2022 Q1 45.3M $1.92B +$61.7M $42.32 124
2021 Q4 43.1M $2.74B +$117M $63.49 122
2021 Q3 34.3M $2.01B +$486M $58.74 113
2021 Q2 26.5M $1.29B +$190M $48.50 109
2021 Q1 22.8M $887M +$90.2M $38.86 94
2020 Q4 20M $1.23B +$52.3M $62.00 72
2020 Q3 16.4M $527M +$527M $32.31 50